|
PRDM5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.30099963924613E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.64449995235339E-09 |
| Normal-vs-Stage2 |
2.839000E-04 |
| Normal-vs-Stage3 |
8.354400E-04 |
| Normal-vs-Stage4 |
2.340400E-03 |
| Stage1-vs-Stage2 |
9.776800E-01 |
| Stage1-vs-Stage3 |
1.148020E-01 |
| Stage1-vs-Stage4 |
8.753000E-01 |
| Stage2-vs-Stage3 |
2.943400E-01 |
| Stage2-vs-Stage4 |
9.171800E-01 |
| Stage3-vs-Stage4 |
4.087400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.20709999773538E-08 |
| Normal-vs-AfricanAmerican |
3.71699999668351E-08 |
| Normal-vs-Asian |
3.561800E-03 |
| Caucasian-vs-AfricanAmerican |
6.168800E-01 |
| Caucasian-vs-Asian |
4.727400E-01 |
| AfricanAmerican-vs-Asian |
5.356600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.64829999941219E-08 |
| Normal-vs-Female |
6.940700E-03 |
| Male-vs-Female |
2.152300E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.032200E-04 |
| Normal-vs-Extreme_Weight |
9.62809999505154E-08 |
| Normal-vs-Obese |
1.58049999998688E-06 |
| Normal-vs-Extreme_Obese |
3.96879999975397E-07 |
| Normal_Weight-vs-Extreme_Weight |
1.282190E-01 |
| Normal_Weight-vs-Obese |
5.432400E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.386150E-02 |
| Extreme_Weight-vs-Obese |
2.620600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.354170E-01 |
| Obese-vs-Extreme_Obese |
8.315800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.59059999999389E-05 |
| Normal-vs-Age(41-60Yrs) |
3.21070000031121E-07 |
| Normal-vs-Age(61-80Yrs) |
2.36340003123559E-09 |
| Normal-vs-Age(81-100Yrs) |
9.380300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.436400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.339600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.001600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.904800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.349200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.085800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.59389999982085E-08 |
| Normal-VS-Type2 PRCC |
1.55420999999878E-05 |
| Normal-VS-KIRP CIMP |
3.216500E-03 |
| Normal-VS-Unclassified PRCC |
3.535800E-03 |
| Type1 PRCC-VS-Type2 PRCC |
6.118300E-03 |
| Type1 PRCC-VS-KIRP CIMP |
4.544000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.639200E-03 |
| Type2 PRCC-VS-KIRP CIMP |
5.844000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.879600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.660400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.41929999980728E-07 |
| Normal-vs-N1 |
8.567800E-04 |
| Normal-vs-N2 |
1.471000E-01 |
| N0-vs-N1 |
1.763570E-01 |
| N0-vs-N2 |
3.070200E-01 |
| N1-vs-N2 |
7.807600E-01 |
|
|
